Staff Profile
Dr Sasha Gartside
Senior Lecturer
- Email: [email protected]
- Telephone: +44 (0) 191 208 7633
- Address: Dr SE Gartside
Senior Lecturer
Biosciences Institute
Faculty of Medical Sciences
Newcastle University
The Medical School
Framlington Place
Newcastle upon Tyne
NE2 4HH
I am a senior lecturer in the Biosciences Institute working in the Neuroscience, Neurodisability and Neurological Disorders Theme in the Faculty of Medical Sciences.
I graduated from Liverpool University with a BSc in Pharmacology in 1986 and from there went to work as a technician in the MRC Clinical Pharmacology Unit at Oxford University. In 1989 I was awarded an MRC studentship and completed my thesis in the Oxford University, Department of Psychiatry supervised by Prof. Phil Cowen. In 1992, I was awarded my DPhil in Neuropharmacology from Wolfson College. I spent a year in Lyon, France as a postdoctoral fellow and then returned to Oxford where I held an MRC Training Fellowship to study the impact of MDMA (ecstasy) on the brain.
In 1999, I moved to Newcastle University to take up a lectureship in the Department of Neurology, Neuroscience and Psychiatry. I am now a senior lecturer in the Biosciences Institute.
Research Interests
I have two main areas of research:
Affective disorders and their treatment.
Affective (mood) disorders (depression and bipolar disorder) are common psychiatric disorders which have a chronic and recurrent course, and are very distressing for sufferers and their families. Patients with affective disorders have not only a reduced quality of life but also a reduced life span and a significant number of patients commit suicide. The aetiology of affective disorders is complex with many ‘risk factors’. Although we have some effective drug treatments for mood disorders, patients take a long time to respond to the drugs and even then may not recover completely; other patients find no benefit at all. In order to better treat, cure, or event prevent affective disorders, we need to understand more about how brain function is altered by both the risk factors for affective disorders and the effective treatments. With this knowledge, I hope that we may be able to vastly improve the treatment of these common and distressing disorders. My research work has particularly focussed on i) gaining a clearer understanding of the anatomy, physiology, and pharmacology of brain monoamine neurotransmitter systems; ii) determining how these neurotransmitter systems are affected by stress and other risk factors for affective disorders; and iii) how these neurotransmitter systems are affected by established and novel antidepressant and mood stabilizing treatments.
The structure, function and plasticity of the auditory midbrain.
Hearing is one of our most important senses. Hearing impairment, and in particular reduced ability to hear speech in noisy environments, is very isolating while hearing disorders including tinnitus (ringing in the ears) and hyperacusis (super sensitivity to sounds) are disabling and distressing. My research is aimed at understanding the structure and function of the auditory system (in particular the auditory midbrain), how activity in the auditory system is modified by other senses and by emotions, and the mechanisms underlying adaptation and mal-adaptation in the auditory system.
In my laboratories I employ a wide range of techniques in rodents including in vivo and in vitro electrophysiology, microdialysis, behavioural analysis, immunocytochemistry, microscopy and optogenetics.
Postgraduate Teaching
I am module leader and I teach the MRes module 'The biological basis of psychiatric disorders and their treatment'
Undergraduate Teaching
I teach on the
Biomedical Sciences and Pharmacology BSc courses
Pharmacy MPharm
MBBS 5 year and accelerated course
Research supervision
I supervise undergraduate project students (BSc and MPharm) and postgraduate (MRes and PhD) research students
Continuing Professional Development
I teach Neuroscience and Psychopharmacology to trainee psychiatrists preparing for the Royal College of Psychiatrists membership examinations (MRCPsych) in the NHS Northern Deanery.
I teach Psychopharmacology to British and overseas health professionals including consultant psychiatrists, nurses and GPs under the auspices of the British Association for Psychopharmacology in Masterclasses and specialist meetings around the country.
I contribute to psychopharmacology content in the British Association for Psychopharmacology's online CPD portfolio
-
Articles
- Olthof BM, Lyzwa D, Gartside SE, Rees A. Nitric oxide signalling underlies salicylate-induced increases in neuronal firing in the inferior colliculus: A central mechanism of tinnitus?. Hearing Research 2022, 424, 108585.
- Gretenkord S, Olthof BMJ, Stylianou M, Rees A, Gartside SE, LeBeau FEN. Electrical stimulation of the ventral tegmental area (VTA) evokes sleep-like state transitions under urethane anaesthesia in the rat medial prefrontal cortex (mPFC) via dopamine D1-like receptors. European Journal of Neuroscience 2020, 52(2), 2915-2930.
- Gartside SE, Yurttaser AE, Burns AL, Jovanovic N, Smith KJ, Amegashiti NS, Olthof BMJ. A role for nitric oxide in serotonin neurons of the midbrain raphe nuclei. European Journal of Neuroscience 2020, 51(9), 1881-1899.
- Othof BMJ, Gartside SE, Rees A. Puncta of Neuronal Nitric Oxide Synthase (nNOS) Mediate NMDA Receptor Signalling in the Auditory Midbrain. Journal of Neuroscience 2019, 39(5), 876-887.
- Olthof BMJ, Rees A, Gartside SE. Multiple non-auditory cortical regions innervate the auditory midbrain. Journal of Neuroscience 2019, 39(45), 8916-8928.
- Gretenkord S, Rees A, Whittington MA, Gartside SE, Lebeau FEN. Dorsal vs. ventral differences in fast Up-state-associated oscillations in the medial prefrontal cortex of the urethane-anesthetized rat. Journal of Neurophysiology 2017, 117(3), 1126-1142.
- Judge SJ, Savy CY, Campbell M, Dodds R, Gomes LK, Laws G, Watson A, Blain PG, Morris CM, Gartside SE. Mechanism for the acute effects of organophosphate pesticides on the adult 5-HT system. Chemico-Biological Interactions 2016, 245, 82-89.
- Pienaar IS, Gartside SE, Sharma P, DePaola V, Gretenkord S, Withers D, Elson JL, Dexter DT. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Molecular Neurodegeneration 2015, 10, 47.
- Savy CY, Fitchett AE, McQuade R, Gartside SE, Morris CM, Blain PG, Judge SJ. Low-level repeated exposure to diazinon and chlorpyrifos decrease anxiety-like behaviour in adult male rats as assessed by marble burying behaviour. Neurotoxicology 2015, 50, 149-156.
- Weber T, Vogt MA, Gartside SE, Berger SM, Lujan R, Lau T, Herrmann E, Sprengel R, Bartsch D, Gass P. Adult AMPA GLUA1 Receptor Subunit Loss in 5-HT Neurons Results in a Specific Anxiety-Phenotype with Evidence for Dysregulation of 5-HT Neuronal Activity. Neuropsychopharmacology 2015, 40(6), 1471-1484.
- French AS, Simcock KL, Rolke D, Gartside SE, Blenau W, Wright GA. The role of serotonin in feeding and gut contractions in the honeybee. Journal of Insect Physiology 2014, 61, 8-15.
- Wallace J, Marston HM, McQuade R, Gartside SE. Evidence that the attentional set shifting test in rats can be applied in repeated testing paradigms. Journal of Psychopharmacology 2014, 28(7), 691-696.
- Wallace J, Marston HM, McQuade R, Gartside SE. Evidence that aetiological risk factors for psychiatric disorders cause distinct patterns of cognitive deficits. European Neuropsychopharmacology 2014, 24(6), 879-889.
- Wallace J, Jackson RK, Shotton TL, Munjal I, McQuade R, Gartside SE. Characterization of electrically evoked field potentials in the medial prefrontal cortex and orbitofrontal cortex of the rat: Modulation by monoamines. European Neuropsychopharmacology 2013, n/a, n/a.
- Picard M, Gentil BJ, McManus MJ, White K, St Louis K, Gartside SE, Wallace DC, Turnbull DM. Acute exercise remodels mitochondrial membrane interactions in mouse skeletal muscle. Journal of Applied Physiology 2013, 115(10), 1562-1571.
- McCardle CE, Gartside SE. Effects of general anaesthetics on 5-HT neuronal activity in the dorsal raphe nucleus. Neuropharmacology 2012, 62(4), 1787-1796.
- Ayissi Mbomo R, Gartside SE, Ngo Bum E, Njikam N, Okello E, McQuade R. Effect of Mimosa pudica (Linn.) extract on anxiety behaviour and GABAergic regulation of 5-HT neuronal activity in the mouse. Journal of Psychopharmacology 2012, 26(4), 575-583.
- Berger SM, Weber T, Perreau-Lenz S, Vogt MA, Gartside SE, Maser-Gluth C, Lanfumey L, Gass P, Spanagel R, Bartsch D. A functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system. Neuropsychopharmacology 2012, 37(9), 1986-1998.
- Yates SJ, Ahuja N, Gartside SE, McAllister-Williams RH. Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods. Therapeutic Advances in Psychopharmacology 2011, 1(4), 125-127.
- Bateson M, Desire S, Gartside SE, Wright GA. Agitated honeybees exhibit pessimistic cognitive biases. Current Biology 2011, 21(12), 1070-1073.
- Gartside SE, Griffith NC, Kaura V, Ingram CD. The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors. Journal of Psychopharmacology 2010, 24(11), 1717-1724.
- Minton GO, Young AH, McQuade R, Fairchild G, Ingram CD, Gartside SE. Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder. Neuropsychopharmacology 2009, 34(10), 2265-2274.
- Johnson DA, Ingram CD, Grant EJ, Craighead M, Gartside SE. Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter. Neuropsychopharmacology 2009, 34(2), 399-409.
- Ferrie LJ, Gartside SE, Martin KM, Young AH, McQuade R. Effect of chronic lithium treatment on D2/3 autoreceptor regulation of dopaminergic function in the rat. Pharmacology Biochemistry and Behavior 2008, 90(2), 218-225.
- Kaura V, Ingram CD, Gartside SE, Young AH, Judge SJ. The progesterone metabolite allopregnanolone potentiates GABAA receptor-mediated inhibition of 5-HT neuronal activity. European Neuropsychopharmacology 2007, 17(2), 108-115.
- Johnson DA, Grant EJ, Ingram CD, Gartside SE. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biological Psychiatry 2007, 62(11), 1228-1235.
- Gartside SE, Cole AJ, Williams AP, McQuade R, Judge SJ. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei. European Journal of Neuroscience 2007, 25(10), 3001-3008.
- Gartside SE, Cowen PJ. Pharmacology of drugs used in the treatment of mood disorders. Psychiatry 2006, 5(5), 162-166.
- Judge SJ, Young RL, Gartside SE. GABAA receptor modulation of 5-HT neuronal firing in the median raphe nucleus: Implications for the action of anxiolytics. European Neuropsychopharmacology 2006, 16(8), 612-619.
- Judge SJ, Gartside SE. Firing of 5-HT neurones in the dorsal and median raphe nucleus in vitro shows differential α1-adrenoceptor and 5-HT1A receptor modulation. Neurochemistry International 2006, 48(2), 100-107.
- Minton GO, Gartside SE. Distribution of glucocorticoid and mineralocorticoid receptors in the rat midbrain ventral tegmental area. European Neuropsychopharmacology 2006, 16(4), S221.
- Judge SJ, Ingram CD, Gartside SE. Moderate differences in circulating corticosterone alter receptor-mediated regulation of 5-hydroxytryptamine neuronal activity. Journal of Psychopharmacology 2004, 18(4), 475-483.
- Judge SJ, Ingram CD, Gartside SE. GABA receptor modulation of 5-HT neuronal firing: characterization and effect of moderate in vivo variations in glucocorticoid levels. Neurochemistry International 2004, 45(7), 1057-1065.
- McQuade R, Leitch MM, Gartside SE, Young AH. Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain. Journal of Psychopharmacology 2004, 18(4), 496-501.
- Hajós M, Gartside SE, Varga V, Sharp T. In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: Role of 5-HT1A receptors. Neuropharmacology 2003, 45(1), 72-81.
- Gartside SE, Leitch MM, McQuade R, Swarbrick DJ. Flattening the glucocorticoid rhythm causes changes in hippocampal expression of messenger RNAs coding structural and functional proteins: implications for aging and depression. Neuropsychopharmacology 2003, 28(5), 821-829.
- Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE. Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology 2003, 28(1), 119-125.
- Gartside SE, Johnson DA, Leitch MM, Troakes C, Ingram CD. Early life adversity programs changes in central 5-HT neuronal function in adulthood. European Journal of Neuroscience 2003, 17(11), 2401-2408.
- Gartside SE, Leitch MM, Young AH. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: Implications for the treatment of depression. Neuropsychopharmacology 2003, 28(9), 1572-1578.
- Johnson DA, Gartside SE, Ingram CD. 5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus. Neuropharmacology 2002, 43(6), 959-965.
- Gartside SE, Hajós-Korcsok E, Bagdy E, Hársing Jr LG, Sharp T, Hajós M. Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 2000, 98(2), 295-300.
- Gartside SE, Clifford EM, Cowen PJ, Sharp T. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. British Journal of Pharmacology 1999, 127(1), 145-152.
- Clifford EM, Gartside SE, Umbers V, Cowen PJ, Hajós M, Sharp T. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. British Journal of Pharmacology 1998, 124(1), 206-212.
- Gartside SE, Umbers V, Sharp T. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms. Psychopharmacology (Berl) 1997, 130(3), 261-268.
- Sharp T, Gartside SE, Umbers V. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release. European Journal of Pharmacology 1997, 320(1), 15-19.
- Sharp T, Umbers V, Gartside SE. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. British Journal of Pharmacology 1997, 121(5), 941-946.
- Gartside SE, McQuade R, Sharp T. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: Comparison between dorsal and median raphe 5-HT systems. Neuropharmacology 1997, 36(11-12), 1697-1703.
- Gartside SE, McQuade R, Sharp T. Effects of repeated administration of 3,4- methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. Journal of Pharmacology and Experimental Therapeutics 1996, 279(1), 277-283.
- T. Sharp, R. McQuade, S. Gartside, V. Umbers and M. Hajos. Antidepressant action on anatomically distinct 5-HT pathways: Combined electrophysiological and neurochemical studies. Journal of Neurochemistry 1996, 66, S35-S35.
- Gartside SE, Umbers V, Hajós M, Sharp T. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. British Journal of Pharmacology 1995, 115(6), 1064-1070.
- Hajós M, Gartside SE, Sharp T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Archives of Pharmacology 1995, 351(6), 624-629.
- Gartside SE, Suaud-Chagny M-F, Tappaz M. Evidence that activation of the hypothalamo-pituitary-adrenal axis by electrical stimulation of the noradrenergic A1 group is not mediated by noradrenaline. Neuroendocrinology 1995, 62(1), 2-12.
- Hajós M, Gartside SE, Villa AEP, Sharp T. Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 1995, 69(1), 189-197.
- Gartside SE, Ellis PM, Sharp T, Cowen PJ. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. European Journal of Pharmacology 1992, 221(1), 27-33.
- Gartside SE, Cowen PJ, Sharp T. Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo. Psychopharmacology (Berl) 1992, 109(1-2), 251-253.
- Gartside SE, Cowen PJ, Sharp T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 1992, 31(1), 9-14.
- Ellis PM, Gartside SE, Ware CJ, Campling GM, Cowen PJ. Does metergoline selectively attenuate 5-HT mediated prolactin release?. Psychopharmacology (Berl) 1991, 105(1), 129-131.
- Anderson IM, Gartside SE, Cowen PJ. The effect of moderate weight loss on overnight melatonin secretion. British Journal of Psychiatry 1990, 156(6), 875-877.
- Gartside SE, Cowen PJ. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors. European Journal of Pharmacology 1990, 179(1-2), 103-109.
- Cowen PJ, Anderson IM, Gartside SE. Endocrinological responses to 5-HT. Annals of the New York Academy of Sciences 1990, 600, 250-257; discussion 257-259.
- Gartside SE, Cowen PJ, Hjorth S. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. European Journal of Pharmacology 1990, 191(3), 391-400.
- Anderson IM, Crook WS, Gartside SE, Fairburn CG, Cowen PJ. The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers. Journal of Affective Disorders 1989, 16(2-3), 197-202.
- Anderson IM, Crook WS, Gartside SE, Parry-Billings M, Newsholme EA, Cowen PJ. Effect of moderate weight loss on prolactin secretion in normal female volunteers. Psychiatry Research 1989, 29(2), 161-167.
- Grasby PM, Begg EJ, Gartside SE, Cowen PJ. Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers. Biological Psychiatry 1989, 26(4), 412-416.
-
Conference Proceedings (inc. Abstracts)
- Wallace J, McQuade R, Marston HM, Gartside SE. Subchronic flattening of the glucocorticoid rhythm induces performance deficits in the attentional set shifting task. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2011, Harrogate: Sage Publications Ltd.
- Gartside SE, Speers SA. Effects of mephedrone on monoamine release in the brain: Comparison with d-amphetamine. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2011, Harrogate: Sage Publications Ltd.
- Wallace J, McQuade R, Marston HM, Gartside SE. Serotonin inhibits field potentials in the medial prefrontal cortex. In: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2010, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS: ELSEVIER SCIENCE BV.